Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype

Authors:

Abstract
No abstract available
Funding Information
  • Bristol-Myers Squibb
  • Toray Industries
  • Pfizer
  • National Institutes of Health
  • GlaxoSmithKline
  • Gilead Sciences
  • UCB
  • Boehringer Ingelheim
  • MedImmune

This publication has 142 references indexed in Scilit: